The dosage of AOD9604 used in this study or 0.25 mg per injection, was carefully calculated to be molar equivalent to doses of full-length GH shown to be effective in prior rabbit OA studies
Accessed October 20, 2024.
It is often stacked with other peptides, such as CJC-1295 or Ipamorelin, to maximize fat-burning and improve body composition results
No significant difference was observed between the groups in terms of time to symptom improvement, time to an increase in serum sodium of 5 mmol/L, or length of hospital stay
The investigators reported that oral AOD-9604 administration in rodent models produced measurable increases in fat oxidation and reductions in body fat, and that direct application of the compound to ex vivo human adipose tissue produced concentration-dependent increases in lipolysis [2]
AOD9604 is a peptide that is considered to be a modified fragment of growth hormone that has been shown to reduce body fat and regulate metabolism